OCTAPHARMA ITALY S.P.A.

It is used to restore and maintain circulating blood volume when a deficiency has been confirmed.

Dosage form: solution for infusion

ATC: B05AA01

It is used for patients (adults and children) who have antibody levels that are too low to fight infections. It is used to treat those born with a reduced ability to produce antibodies or those who have developed an antibody deficiency due to specific diseases or treatments.

Dosage form: solution for injection

ATC: J06BA01

It is used as replacement therapy for children, adolescents, and adults with antibody deficiencies (both congenital and acquired) and to protect those exposed to measles. It can also be used for certain autoimmune diseases such as immune thrombocytopenia, Kawasaki disease, Guillain-Barré syndrome, CIDP, multifocal motor neuropathy, and dermatomyositis.

Dosage form: solution for infusion

ATC: J06BA02

It is used as replacement therapy for children, adolescents, and adults with antibody deficiencies (both congenital and acquired) and for protection against diseases such as measles in susceptible individuals. It is also used to treat certain autoimmune disorders, including immune thrombocytopenia (ITP), Kawasaki disease, Guillain-Barré syndrome, CIDP, and multifocal motor neuropathy (MMN).

Dosage form: solution for infusion

ATC: J06BA02

It is used as replacement therapy for children, adolescents, and adults with antibody deficiencies (both congenital and acquired) or for those at risk of measles exposure. It can also be used to treat certain autoimmune diseases such as immune thrombocytopenia, Kawasaki disease, Guillain-Barré syndrome, CIDP, and multifocal motor neuropathy.

Dosage form: solution for infusion

ATC: J06BA02

It is used for the treatment and prevention of bleeding in patients with hemophilia A, a condition caused by an inherited deficiency of coagulation factor VIII.

Dosage form: solution for injection, powder and solvent

ATC: B02BD06

It is used for the treatment and prevention of bleeding in patients with hemophilia B, a condition caused by a hereditary deficiency of coagulation factor IX.

Dosage form: solution for injection, powder and solvent

ATC: B02BD04

Octanorm contains antibodies that protect the body and increase resistance to infections. It is used as replacement therapy for adults, children, and adolescents with reduced capacity to produce immunoglobulins, and for patients with chronic lymphocytic leukemia, multiple myeloma, or antibody deficiency before and after a hematopoietic stem cell transplant.

Dosage form: solution for injection

ATC: J06BA01

It is used for the treatment and prevention of bleeding caused by vitamin K antagonists (such as warfarin) and for people with a congenital deficiency of coagulation factors II and X, when the specific purified factor is not available.

Dosage form: solution for injection/infusion, powder and solvent for preparation of

ATC: B02BD01

It is used to prevent immunization in Rh-negative women during pregnancy and childbirth, thereby protecting the fetus from potential harm. It is indicated in cases such as the birth of an Rh-positive baby, miscarriages, ectopic pregnancies, invasive procedures during pregnancy (such as amniocentesis), abdominal trauma, or in the event of accidental Rh-positive blood transfusions.

Dosage form: solution for injection

ATC: J06BB01

Wilate is used to treat and prevent bleeding in patients with Von Willebrand disease (VWD) or hemophilia A.

Dosage form: solution for injection, powder and solvent

ATC: B02BD06